Analytical Chemistry Assays

Analytical Chemistry Assays

Analyte

Sample Type

Instrument

2-AG(2-Arachidonoylglycerol), AEA(N-arachidonoylethanolamine)Brain, brain perfusateHPLC-MS/MS
 4-HPR (N-(4-hydroxyphenyl)-retinamide)Plasma; TissueHPLC-FLD 
5-FU (Fluorouracil)CellsHPLC-MS/MS
8-Hydroxy-2'-deoxyguanosineUrine; DNA HPLC-MS/MS 
8-Isoprostaglandin F2 alpha Urine; PlasmaHPLC-MS/MS
AcetylcholineMouse cortexHPLC-MS/MS
AH1S2(iron chelator)Mouse PlasmaHPLC-MS/MS
Alpha-tocopheryloxyacetic acidPlasmaHPLC-MS/MS
Amino AcidsCell CultureHPLC-MS/MS
AMP423(naphthyl derivative of 2-cyanoaziridine-1-carboxamide)Formulation PreparationHPLC-MS 
AspirinPlasmaHPLC-MS/MS
Antalarmin Plasma HPLC-MS/MS 
Arginine/OrnithineIntestine;
Colon Tissue
HPLC-FLD 
AZ002SMouse PlasmaHPLC-MS/MS
AZD/PonatinibPlasmaHPLC-MS/MS
Bile acidsFecal Water; Plasma;
Intestinal fluid
HPLC-MS 
Bile acids (parent bile acids and taurine and glycine conjugates)Gastric fluidHPLC-MS/MS 
BixinPlasmaHPLC-UV
Buspirone Plasma HPLC-MS/MS 
C391PlasmaHPLC-UV-MS
Caffeine/Caffeine metabolites Plasma HPLC-UV;
HPLC-MS/MS
Carbendazim Plasma HPLC-MS/MS 
CarotenoidsPlasma; Skin HPLC-FLD 
Celecoxib Plasma HPLC-UV 
CeramideCells; plasma;
Urine; tissue
*HPLC-MS/MS 
Ceramide-1-PhosphateCells; plasma;
Urine; tissue
*HPLC-MS/MS 
cGMPCell ExtractHPLC-MS/MS
Chlorophyll Colon Tissue HPLC-FLD
Compound LMouse PlasmaHPLC-MS/MS
Cortisol/6-Hydroxycortisol UrineHPLC-UV 
Cortisol/Cortisone SalivaHPLC-MS/MS 
CurcuminPlasma; Urine; Skin HPLC-UV;
HPLC-MS/MS
Cytarabine + nucleosidesCellsHPLC-MS/MS
DexmedetomidineUrineHPLC-MS/MS 
Dextromethorphan (DM)/DM metabolitesUrine HPLC-FLD 
DFMO (Alpha-difluoromethylornithine)Plasma; Skin HPLC-FLD
DiacylglyceridesCells; plasma;
Urine; tissue
*HPLC-MS/MS 
DihydrotestosteroneCytosolic extractHPLC-MS
DIM (diindolylmethane)UrineHPLC-MS/MS
DiphenidolCell culture mediaHPLC-MS/MS
DITPA (3,5-diiodothyropropionic acid) Plasma HPLC-MS/MS
DopamineMouse CortexHPLC-MS/MS
DoxorubicinTissue (mouse tumor)UPLC-TOF-MSe
DPC0046PlasmaHPLC-MS/MS
EndocannabinoidsPlasma*HPLC-MS/MS
EpinephrineMouse cortexHPLC-MS/MS
Estrone/Estradiol +13 metabolitesPlasma; urineHPLC-MS/MS
Fatty acidsPlasmaHPLC-MS/MS
FICZ(6-Formylindolo(3,2-b)carbazole)PBSHPLC-MS
GABA (gamma-aminobutyric acid)Mouse Cortex; UrineHPLC-MS/MS 
gamma-Glutamylcysteine Cell extract HPLC-FLD 
Gemcitabine TriphosphateBlood Lymphocytes;
Cell Extract
HPLC-UV
Gemcitabine Plasma; Tissue; Cell Extract HPLC-UV;
HPLC-MS/MS
GenisteinPlasmaHPLC-MS/MS
GlutamateMouse CortexHPLC-MS/MS 
Glyoxal, Methyl glyoxalCell extractGC-MS
5-,8-,11-,12-,15-,20-HETEs (hydroperoxyeicosatetraenoic acid)Lung Tissue HPLC-MS/MS
Hexosylceramide/LactosylCerCells; plasma; Urine; tissue*HPLC-MS/MS 
HPMA(N-(2-Hydroxypropyl)methacrylamide), SPMA
(S-phenyl mercapturic acid),
HMPMA(3-hydroxy-1-methylpropylmercapturic acid)
UrineHPLC-MS/MS
ImexonPlasma HPLC-UV 
IronCell ExtractAAS
Isothiocyanate-glutathione conjugatesCultured cells HPLC-MS/MS 
Kynurenine Pathway Metabolites***Urine, plasma, liverHPLC-MS/MS
LTE4(Leukotriene E4)UrineHPLC-MS/MS
Limonene Plasma; breast tissue,
adipose tissue 
HPLC-MS/MS;
GC-MS 
Losartan/Losartan MetabolitesUrine; PlasmaHPLC-UV;
HPLC-MS/MS
MalondialdehydeCell extractGC-MS
Melphalan/Melphalan analoguesDosing Preparation HPLC-MS/MS
MetforminPlasma; Cell culture media;
Tissue
HPLC-MS/MS 
Methyl-4-aminosalicylatePure StandardHPLC-UV
MetronidazoleCellsHPLC-MS/MS
Midazolam/ Midazolam MetabolitesPlasmaHPLC-MS/MS
NapthazarinPure StandardHPLC-UV-MS/MS
Nitotinic acid/NicotinamidePlasma HPLC-MS/MS
NitriteCell culture mediaHPLC-FLD
NorepinephrineMouse cortexHPLC-MS/MS
NPA-093PlasmaHPLC-UV
Nucleoside Triphosphates/deoxyNucleoside TriphosphatesCell extractHPLC-MS/MS
Omeprazole/MetabolitesPlasmaHPLC-MS/MS
Oxylipins(69 individual**)PlasmaUPLC-TOF-MS
PazopanibPlasmaHPLC-MS/MS
Pemetrexed (Alimta®)Plasma; IP fluidHPLC-MS/MS
PentosidinePlasmaHPLC-FLD
PGE-MUrineHPLC-MS/MS
PhenethylamineUrineHPLC-MS/MS
Phthalates (mono- and di-butyl phthalate)Plasma; TissueHPLC-MS/MS
PHT-427 (Akt/phosphatidylinositide-dependent
Protein Kinase 1 Pleckstrin Homology Domain Inhibitor)
Plasma; TissueHPLC-UV;
HPLC-MS/MS
PhytoCeramideYeast*HPLC-MS/MS 
PMIP (therapeutic peptide)PlasmaHPLC-MS/MS 
PolyaminesPlasma; TissueHPLC-FLD 
Psorospermin methyl etherPlasmaHPLC-UV 
PX-12(1-methylpropyl 2-imidazolyl disulfide)Plasma HPLC-UV;
HPLC-MS/MS
QuercetinPlasma; skinHPLC-MS/MS
RadicicolPlasmaHPLC-MS/MS
RapamycinWhole bloodHPLC-MS/MS
ResveratrolPlasma; TissueHPLC-MS/MS 
Retinols(Retinol, all-trans retinoic acid, 9-cis retinoic acid)Plasma; Skin, Mouse TissueHPLC-FLD/HPLC-MS/MS
SeleniumPlasma, prostate tissue AA 
SerotoninPlasma; Tissue; UrineHPLC-MS/MS
SGM45Mouse PlasmaHPLC-MS/MS
Sphingosine/Sphinogsine-1-PCells; plasma; Urine; tissue*HPLC-MS/MS 
SphingomyelinCells; plasma; Urine; tissue*HPLC-MS/MS 
Sulindac/Sulindac metabolitesPlasma; Breast Fluid; Skin HPLC-MS/MS 
TargretinPlasmaHPLC-FLD 
TaurineUrineHPLC-MS/MS
Tea CatechinsPlasma; Urine HPLC-EC 
TestosteronePlasmaHPLC-MS/MS 
TC1S2(iron chelator)Mouse PlasmaHPLC-MS/MS
TC4G6(iron chelator)Mouse PlasmaHPLC-MS/MS
Thyroxine/TriiodothyroxinePlasma HPLC-MS/MS 
Tocopherol/Tocopherol succinatePlasma; Tissue HPLC-FLD
UA8967PlasmaHPLC-MS/MS
Withaferin analoguesPlasmaHPLC-MS/MS 
Wortmannin analoguesPlasma; BileHPLC-MS/MS
ZileutonPlasmaHPLC-MS/MS

DISCOVERY (untargeted) Metabolomics and Lipidomics –

Analysis is performed on most sample types listed above.  The analysis is performed on a Thermo Vanquish Dual UPLC/Exploris 480 Orbi(producing HRAM spectra).   Chromatographic strategies include Reverse Phase and HILIC (With lipid specific chromatography for Lipidomics).  Sample preparation is available through the resource. Samples are processed utilizing Thermo Compound Discoverer and/or Lipid Search Software, statistical analysis utilizes R and Metaboanalyst.  As this is typically a tailored analysis please inquire with ACSR for a consultation to discuss projects.

* = available through Sub-core

** = 9-HOTrE, 13-HOTrE, 13-oxo-ODE, 9-oxo-ODE, 13-HODE, 9-HODE, 12(13)-EpOME, 9(10)-EpOME, EKODE, 12,13-DiHOME, 9,10-DiHOME, 15-deoxy-Prostaglandin J2, 15-HEPE, 8-HEPE, 12-HEPE, 5-HEPE, 17(18)-EpETE, 15-oxo-ETE, 14(15)-EpETE, 11(12)-EpETE, 8(9)-EpETE, 12-oxo-ETE, 5-oxo-ETE, 20-HETE, 15-HETE, 11-HETE, 8-HETE, 12-HETE, 9-HETE, 5-HETE, 14(15)-EET, 11(12)-EET, 8(9)-EET, 5(6)-EET, 15(S)-HETrE, Prostaglandin J2, Prostaglandin B2, 8,15-DiHETE, 6-trans-Leukotriene B4, 5,15-DiHETE, 17,18-DiHET, Leukotriene B4, 14,15-DiHETE, 5,6-DiHETE, 14,15-DiHET, Leukotriene B3, 11,12-DiHET, 8,9-DiHET, 5,6-DiHET, 17-HDHA, 19(20)-EpDPA, 16(17)-EpDPA, 13(14)-EpDPA, 10(11)-EpDPA, 7(8)-EpDPA, Prostaglandin E3, Prostaglandin D3, 20-OH-Leukotriene B4, Prostaglandin E2, Prostaglandin D2, Lipoxin A4, Prostaglandin F2a, Prostaglandin E1, Prostaglandin D1, 19,20-DiHDPE, 20-COOH-LTB4, 6-keto-PGF1a, TXB2, Resolvin D1

*** = 3-hydroxyanthranilic acid, quinolinic acid, anthranilic acid, L-tryptophan, L-kynurenine, kynurenic acid, 3-hydroxykynurenine, cinnabarinic acid, xanthurenic acid, N-formylkynurenine, picolinic acid, 5-hydroxytryptophan, serotonin, melatonin, tryptamine, glutamic acid, dopamine
 

To build a project, get a quote, or order a service within iLab:

Please remember to acknowledge the Cancer Center Support Grant (P30 CA023074) when publishing manuscripts or abstracts that utilized the services of the University of Arizona Cancer Center’s Shared Resources and/or were derived from CCSG pilot funds. Suggested language: "Research reported in this [publication/press release] was supported by the National Cancer Institute of the National Institutes of Health under award number P30 CA023074.

Contact

UACC-ACSR@uacc.arizona.edu

Potential users, especially first-time users, are encouraged to personally contact ACSR service personnel for instructions on how to access all the services of the Analytical Chemistry Shared Resource. 

Please contact Dr. Snider by phone or email. After a short discussion about your project, the service request form can be submitted to the ACSR and a realistic timeline can be projected.

All University of Arizona Cancer Center members have access to the Analytical Chemistry Shared Resource. The service is provided according to the following University of Arizona Cancer Center priority guidelines

  1. University of Arizona Cancer Center members with peer-reviewed extramural funding;
  2. New University of Arizona Cancer Center investigators with University of Arizona Cancer Center pilot project or developmental funding;
  3. University of Arizona Cancer Center members with other funding sources;
  4. Peer-reviewed, funded non-members at University of Arizona if sufficient time/resources are available to accommodate requested service.